Liquidia Technologies

Liquidia Technologies

To improve the quality of human life.

United States of America | Community Development |

 

Overview

Liquidia Technologies is developing highly precise particle based vaccines and therapeutics for the prevention and treatment of human disease. Combining a deep understanding of particle based drug development with breakthrough small molecule and biological therapeutics Liquidia is engineering vaccines and therapies that have the potential to dramatically improve the quality of human life.

Industry

Legal Structure

Operating Status

Employees

Operating 51 - 200 employees

Funding and Financing Rounds


Team


Impact

Social Objectives:

Environmental Objectives:

Operational Impact:


Impact Reports & Metrics


Offices

Headquarters

419 Davis Drive, Suite 100
Morrisville, North Carolina 27560
United States of America



Explore

Revision History

Last Update: Dec 09, 2017 5:45 a.m.

Quick Search



  • Global  
  • Africa  
  • Americas  
  • Asia  
  • Europe  
  • Oceania  


Incoming

Tags

COPYRIGHT 2018 IMPACTSPACE. ALL RIGHTS RESERVED.